Despite high levels of transparency and predictability associated with the Slovenian regulatory processes, registration procedures, pricing and reimbursement policies, implementing appropriate local pharmacovigilance requirements requires considerable local insight. Furthermore, given increasing dialogue within and across the wider Slovenian healthcare industry and the need to anticipate any resulting regulatory change, access to a local regulatory partner and to local QPPV services is an essential pre-requisite to executing successful market entry and development.

As a specialist healthcare consulting firm, Grove’s expertise in Slovenia spans four key areas:

• regulatory affairs consulting, including regulatory intelligence
• pharmacovigilance services
• market access, including pricing and reimbursement applications
• market assessment including opportunity evaluation, regulatory risk assessment and intelligence on medical device regulations

GROVE AS YOUR PARTNER IN SLOVENIA FOR REGULATORY AFFAIRS, PHARMACOVIGILANCE AND MARKET ACCESS

For over twenty years Grove has successfully provided regulatory, PV and market access services to a wide range of clients to help them navigate the specifics of the Slovenian market. With experienced consultants based full-time in the market, clients gain access to an unrivalled depth of local knowledge and understanding in all areas associated with entering and operating in the country.

Pharmaceutical consulting, regulatory affairs, pharmacovigilance, market access and market assessment services are all key areas of Grove’s expertise.